Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 21, 2021.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Matthew B. Harms, MD, in honor of ALS Awareness Month, who detailed the impact that awareness efforts have had on improving patient care and some of the latest research and advances that have been made in amyotrophic lateral sclerosis.
In this segment of the NeurologyLive Peers & Perspectives, "Dystrophin and Its Role in Effective Treatment of Duchenne Muscular Dystrophy," Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, discuss microdystrophin, its place in gene therapy, and relevance in the clinical setting in relation to Duchenne muscular dystrophy.
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed treatment optimization for patients with migraine and raising overall awareness for preventive treatments.
In data released by the National Headache Foundation, nearly 65% of responders said their migraine disease makes them feel like life is passing them by, and more than 50% claimed they cannot make plans with friends or family because of the unpredictability of their disease.
In this segment of the NeurologyLive Peer Exchange, "Management of Progressive Multiple Sclerosis," Bruce Cree, MD, PhD; Joseph R. Berger, MD; Kristen Krysko, MD; Fred D. Lublin, MD; and Robert Fox, MD, offer advice to community physicians and neurologists in managing patients with multiple sclerosis.
Don't miss your chance to see this month's free webinar, part of our series "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers. You'll join Ahmed Obeidat, MD, PhD; Mitch Freedman, MD; and Suma Shah, MD, in the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
To view the enduring version of either of the first two programs, click here for our Future Leaders in Neurology section.